Secondary progressive MS is a stage of MS which comes after relapsing remitting MS for many people. With this type of MS your disability gets steadily worse. Find out more about what changes might happen.
NICE says initial no to ocrelizumab for primary progressive MS
National Institute for Health and Care Excellence (NICE) provisionally decide not to recommend ocrelizumab for people with primary progressive MS on the NHS. This is the first stage of their review into this new MS treatment.